Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 874

Sols Systems walks away with funding

3D printed orthotic company, Sols, gains $1.75m in seed funding led by Lux Capital.

Apr 1, 2014

Rise Labs raises healthy investment

Rise Labs, creators of a nutrition and lifestyle coaching smart phone app, has raised $2.3m in funding led by Floodgate with participation from Google Ventures.

Apr 1, 2014

$2.8m funding for Transcriptic

US-based Transcriptic, a Google-backed provider of automated scientific services, has raised an additional $2.8m in financing led by IA Ventures.

Apr 1, 2014

Losing pounds gains dollars for Noom

Noom, a US-based health and fitness application company, has raised $7m in series A funding led by RRE Venures and including Qualcomm.

Apr 1, 2014

Jaguar snags $2m in funding

Jaguar Animal Health, headquartered in San Francisco and backed by Napo Pharmaceuticals, has closed its series A funding round led by BioVeda China Fund with an investment of $2m.

Apr 1, 2014

UniQure raises $91.8m in IPO

UniQure, a gene-therapy company based in The Netherlands, has closed its initial public offering which raised $91.8m by selling 5.4 million shares of common stock.

Apr 1, 2014

scPharmaceuticals closes series A with $16m

Lundbeck's corporate venturing unit has co-led company's series A round, and the funds will be used to develop the pipeline for its two lead treatment options.

Mar 31, 2014

RuiYi looks to China after $15m round

Merck Serono and GlaxoSmithKline have both invested in a $15m round for the biopharmaceutical company, which is focusing its treatments on the Chinese market.

Mar 31, 2014

Intel eyes promise in OrCam's vision

Intel's corporate venturing unit has invested a reported $15m in OrCam Technologies, which is developing special eyeglasses to help the blind.

Mar 31, 2014

AGTC sees $50m in proceeds from IPO

The biopharmaceutical company, which has investors including the corporate venturing subsidiaries of GlaxoSmithKline and MedImmune, has secured $50m from its initial public offering.

Mar 31, 2014
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here